CAVEI supports the MoH strategy of offering a second booster dose to immunosuppressed people, health workers and residents and workers of long-term care homes with COVID-19 vaccine preferably mRNA vaccines and 16 weeks apart from the first booster against SARS-CoV-2.
CAVEI also recommends a second booster dose for the general population in consideration of the objective of preventing morbidity and mortality from COVID-19 in other groups and preserving the health system against a potential scenario of co-circulation of SARSCoV-2 with other respiratory viruses during the winter period, thus preventing stress and the increase in the demand for health care. The second booster vaccination in the general population should preferably be with the COVID-19 vaccine based on mRNA and 16 weeks apart from the first vaccination booster against SARS-CoV-2.

  • Recommendation
  • Americas
  • Chile
  • booster dose
  • COVID-19